FdaApplication
ANDA 210929
Identifiers
- fda_app_no: ANDA210929
Properties
| Property | Value |
|---|---|
| applicant_name | HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD |
| application_type | ANDA |
| approval_date | 2023-04-17 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TACROLIMUS | TACROLIMUS | EQ 0.5MG BASE | CAPSULE;ORAL |
| TACROLIMUS | TACROLIMUS | EQ 1MG BASE | CAPSULE;ORAL |
| TACROLIMUS | TACROLIMUS | EQ 5MG BASE | CAPSULE;ORAL |
3 products